Monitoring key biomarkers, such as HbA1c levels, liver enzymes, kidney function, and lipid profiles, ensures that any underlying issues are identified and addressed promptly
Clinical studies for branded medications like Mounjaro and Zepbound have shown that as the dose increases, the likelihood of gastrointestinal side effects can also rise
Key exclusion criteria were recent diabetes or obesity medication use, uncontrolled and potentially unstable diabetic retinopathy or maculopathy, renal impairment, recent cardiovascular events or planned revascularization, history of pancreatis, and expected lifestyle changes
These updated warnings include further advice for patients using oral contraceptives: Patients taking tirzepatide are advised to switch to a non-oral contraceptive or add a barrier method of contraception for 4 weeks after first taking the medicine and for 4 weeks after each increase in the dose
Q: What is the flavor of this effervescent drink
PMID: 31600725